Back to company

Aktieselskabet af 16. februar 2024: Financial statements 2016

CVR: 33034911

Aktieselskabet af 16. februar 2024 (CVR 33034911) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 31,881,881 and a net result of DKK 4,103,877 compared with DKK 5,492,392 the year before. That is an increase of 27.5% compared with the year before. Equity amounted to DKK 10,475,289. The solvency ratio was 29%. The company had 35 employees in the financial year.

Gross Profit
31,881,881 kr.
Profit/Loss
4,103,877 kr.
Equity
10,475,289 kr.
Total Assets
36,142,600 kr.
Employees
35

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-31.9 mio.4.1 mio.10.5 mio.35
2015-25 mio.5.5 mio.6.4 mio.-
2014-13.7 mio.3.2 mio.3.7 mio.-
2013-9.8 mio.1.5 mio.527 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Aktieselskabet af 16. februar 2024?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

Aktieselskabet af 16. februar 2024: The 2015 annual report is outMay 10, 2016

Aktieselskabet af 16. februar 2024 has published its annual report for 2015. Gross profit came to DKK 24,997,008, and the net result was DKK 5,492,392.

About Aktieselskabet af 16. februar 2024

Aktieselskabet af 16. februar 2024 was a Danish company of the type Aktieselskab based in København K, founded in 2010. The company was registered under the industry Speciallægers aktiviteter. The company was previously named TFP Stork Fertility A/S and STORK IVF KLINIK A/S. The company is owned by VivaNeo DK ApS. The company has 54 employees. In 2023, the company reported a gross profit of DKK 14,491,315 and a net result of DKK -13,702,784 compared with DKK -8,491,214 the year before. Equity amounted to DKK -27,031,558.